Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

November 23, 2026

Study Completion Date

November 23, 2027

Conditions
Ventricular TachycardiaIschemic Cardiomyopathy
Interventions
PROCEDURE

Ablation-index guided ventricular tachycardia ablation

As described in arms descriptions

PROCEDURE

Ventricular tachycardia ablation with no AI-guidance

As described in arms descriptions

Trial Locations (5)

29425

NOT_YET_RECRUITING

Medical University of South Carolina, Charleston

48109

NOT_YET_RECRUITING

Medical University of Michigan, Ann Arbor

55905

NOT_YET_RECRUITING

Mayo Clinic, Rochester

60614

RECRUITING

Rush University Medical Center, Chicago

02115

NOT_YET_RECRUITING

Mass General Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Michigan

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

Biosense Webster, Inc.

INDUSTRY

collaborator

Mayo Clinic

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Rush University Medical Center

OTHER

NCT06138873 - Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy | Biotech Hunter | Biotech Hunter